Results for tag: "Calcinosis Cutis Drug"

Calcinosis Cutis is a rare disorder of the skin and subcutaneous tissue characterized by the deposition of calcium salts. It is a type of Endocrine and Metabolic Disorders Drug, and is typically treated with a combination of topical and systemic medications. Topical medications, such as corticosteroids, are used to reduce inflammation and pain, while systemic medications, such as bisphosphonates, are used to reduce calcium deposits. Other treatments, such as phototherapy and extracorporeal shockwave therapy, may also be used. The Calcinosis Cutis Drug market is a small but growing market, with a focus on developing treatments that are both effective and safe. Companies in the market include AbbVie, Amgen, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Merck, Novartis, Pfizer, and Sanofi. Show Less Read more